Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Vias Partners LLC currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. The prosecution of this portfolio involves 1 distinct examiner and 1 distinct art unit. ROBERTS, LEZAH is identified as the busiest examiner, currently handling 1 pending office action for the company.
This data indicates a concentrated prosecution effort, with the 1 pending office action being the sole point of activity. Because the portfolio is restricted to 1 distinct art unit and 1 distinct examiner, the immediate success of the company's patent filings in Biotechnology & Pharmaceuticals relies on the specific interactions with ROBERTS, LEZAH. The absence of multiple pending actions or examiners suggests that the company is not currently managing a high volume of simultaneous patent office interactions. Practitioners should focus on the specific procedural requirements of the 1 distinct art unit involved, as there is no internal data available to compare performance across different pharmaceutical examination groups.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, LEZAH | 1 | 48.6% | +35.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18726390 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HAIR LOSS | ROBERTS, LEZAH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18726390 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HAIR LOSS | ROBERTS, LEZAH | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18726390 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HAIR LOSS | ROBERTS, LEZAH | 1612 | §103§112 | Non-Final OA | — | Pending | Jul 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVias Partners LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lezah Roberts has the most, with 1 of Vias Partners LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
